(Q53318991)

13 May 2018

title

Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck. (English)

1 reference

13 May 2018

1 reference

4

Claus Rödel

1 reference

13 May 2018

Panagiotis Balermpas

1

1 reference

13 May 2018

Markus Hambek

series ordinal

2

1 reference

13 May 2018

Oliver Seitz

series ordinal

3

1 reference

13 May 2018

Christian Weiss

series ordinal

5

1 reference

13 May 2018

publication date

1 December 2009

1 reference

13 May 2018

Strahlentherapie und Onkologie

published in

1 reference

13 May 2018

volume

185

1 reference

13 May 2018

issue

12

1 reference

13 May 2018

page(s)

775-781

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s00066-009-2092-7

exact match

0 references

cites work

RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00066-009-2092-7

Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes

21 January 2018

1 reference

12 December 2020

Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer

1 reference

12 December 2020

Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?

1 reference

12 December 2020

Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?

1 reference

12 December 2020

Survival times in end-stage head and neck cancer

1 reference

12 December 2020

Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911

1 reference

12 December 2020

Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.

1 reference

12 December 2020

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

1 reference

12 December 2020

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

1 reference

12 December 2020

Squamous cancer of the head and neck: surgical treatment of local and regional recurrence

1 reference

12 December 2020

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Reirradiation in squamous cell head and neck cancer: recent developments and future directions

1 reference

12 December 2020

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

1 reference

12 December 2020

Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer

1 reference

12 December 2020

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

12 December 2020

Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients

1 reference

12 December 2020

Hypofractionated reirradiation for recurrent malignant glioma.

1 reference

12 December 2020

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

12 December 2020

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

10.1007/S00066-009-2092-7

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018